UniProt ID | NOTC1_MOUSE | |
---|---|---|
UniProt AC | Q01705 | |
Protein Name | Neurogenic locus notch homolog protein 1 | |
Gene Name | Notch1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 2531 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein. Notch 1 intracellular domain: Nucleus . Following proteolytical processing NICD is translocated to the nucleus. Nuclear location may require MEGF10. |
|
Protein Description | Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. Involved in angiogenesis; negatively regulates endothelial cell proliferation and migration and angiogenic sprouting. Involved in the maturation of both CD4+ and CD8+ cells in the thymus. Important for follicular differentiation and possibly cell fate selection within the follicle. During cerebellar development, functions as a receptor for neuronal DNER and is involved in the differentiation of Bergmann glia. Represses neuronal and myogenic differentiation. May play an essential role in postimplantation development, probably in some aspect of cell specification and/or differentiation. May be involved in mesoderm development, somite formation and neurogenesis. May enhance HIF1A function by sequestering HIF1AN away from HIF1A. Required for the THBS4 function in regulating protective astrogenesis from the subventricular zone (SVZ) niche after injury. Involved in determination of left/right symmetry by modulating the balance between motile and immotile (sensory) cilia at the left-right organiser (LRO).. | |
Protein Sequence | MPRLLTPLLCLTLLPALAARGLRCSQPSGTCLNGGRCEVANGTEACVCSGAFVGQRCQDSNPCLSTPCKNAGTCHVVDHGGTVDYACSCPLGFSGPLCLTPLDNACLANPCRNGGTCDLLTLTEYKCRCPPGWSGKSCQQADPCASNPCANGGQCLPFESSYICRCPPGFHGPTCRQDVNECSQNPGLCRHGGTCHNEIGSYRCACRATHTGPHCELPYVPCSPSPCQNGGTCRPTGDTTHECACLPGFAGQNCEENVDDCPGNNCKNGGACVDGVNTYNCRCPPEWTGQYCTEDVDECQLMPNACQNGGTCHNTHGGYNCVCVNGWTGEDCSENIDDCASAACFQGATCHDRVASFYCECPHGRTGLLCHLNDACISNPCNEGSNCDTNPVNGKAICTCPSGYTGPACSQDVDECALGANPCEHAGKCLNTLGSFECQCLQGYTGPRCEIDVNECISNPCQNDATCLDQIGEFQCICMPGYEGVYCEINTDECASSPCLHNGHCMDKINEFQCQCPKGFNGHLCQYDVDECASTPCKNGAKCLDGPNTYTCVCTEGYTGTHCEVDIDECDPDPCHYGSCKDGVATFTCLCQPGYTGHHCETNINECHSQPCRHGGTCQDRDNSYLCLCLKGTTGPNCEINLDDCASNPCDSGTCLDKIDGYECACEPGYTGSMCNVNIDECAGSPCHNGGTCEDGIAGFTCRCPEGYHDPTCLSEVNECNSNPCIHGACRDGLNGYKCDCAPGWSGTNCDINNNECESNPCVNGGTCKDMTSGYVCTCREGFSGPNCQTNINECASNPCLNQGTCIDDVAGYKCNCPLPYTGATCEVVLAPCATSPCKNSGVCKESEDYESFSCVCPTGWQGQTCEVDINECVKSPCRHGASCQNTNGSYRCLCQAGYTGRNCESDIDDCRPNPCHNGGSCTDGINTAFCDCLPGFQGAFCEEDINECASNPCQNGANCTDCVDSYTCTCPVGFNGIHCENNTPDCTESSCFNGGTCVDGINSFTCLCPPGFTGSYCQYDVNECDSRPCLHGGTCQDSYGTYKCTCPQGYTGLNCQNLVRWCDSAPCKNGGRCWQTNTQYHCECRSGWTGVNCDVLSVSCEVAAQKRGIDVTLLCQHGGLCVDEGDKHYCHCQAGYTGSYCEDEVDECSPNPCQNGATCTDYLGGFSCKCVAGYHGSNCSEEINECLSQPCQNGGTCIDLTNSYKCSCPRGTQGVHCEINVDDCHPPLDPASRSPKCFNNGTCVDQVGGYTCTCPPGFVGERCEGDVNECLSNPCDPRGTQNCVQRVNDFHCECRAGHTGRRCESVINGCRGKPCKNGGVCAVASNTARGFICRCPAGFEGATCENDARTCGSLRCLNGGTCISGPRSPTCLCLGSFTGPECQFPASSPCVGSNPCYNQGTCEPTSENPFYRCLCPAKFNGLLCHILDYSFTGGAGRDIPPPQIEEACELPECQVDAGNKVCNLQCNNHACGWDGGDCSLNFNDPWKNCTQSLQCWKYFSDGHCDSQCNSAGCLFDGFDCQLTEGQCNPLYDQYCKDHFSDGHCDQGCNSAECEWDGLDCAEHVPERLAAGTLVLVVLLPPDQLRNNSFHFLRELSHVLHTNVVFKRDAQGQQMIFPYYGHEEELRKHPIKRSTVGWATSSLLPGTSGGRQRRELDPMDIRGSIVYLEIDNRQCVQSSSQCFQSATDVAAFLGALASLGSLNIPYKIEAVKSEPVEPPLPSQLHLMYVAAAAFVLLFFVGCGVLLSRKRRRQHGQLWFPEGFKVSEASKKKRREPLGEDSVGLKPLKNASDGALMDDNQNEWGDEDLETKKFRFEEPVVLPDLSDQTDHRQWTQQHLDAADLRMSAMAPTPPQGEVDADCMDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILLRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNKEETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQLHGTALGGTPTLSPTLCSPNGYLGNLKSATQGKKARKPSTKGLACGSKEAKDLKARRKKSQDGKGCLLDSSSMLSPVDSLESPHGYLSDVASPPLLPSPFQQSPSMPLSHLPGMPDTHLGISHLNVAAKPEMAALAGGSRLAFEPPPPRLSHLPVASSASTVLSTNGTGAMNFTVGAPASLNGQCEWLPRLQNGMVPSQYNPLRPGVTPGTLSTQAAGLQHSMMGPLHSSLSTNTLSPIIYQGLPNTRLATQPHLVQTQQVQPQNLQLQPQNLQPPSQPHLSVSSAANGHLGRSFLSGEPSQADVQPLGPSSLPVHTILPQESQALPTSLPSSMVPPMTTTQFLTPPSQHSYSSSPVDNTPSHQLQVPEHPFLTPSPESPDQWSSSSPHSNISDWSEGISSPPTTMPSQITHIPEAFK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 (in isoform 3) | Phosphorylation | - | 10.26 | 22871156 | |
65 | O-linked_Glycosylation | QDSNPCLSTPCKNAG CCCCCCCCCCCCCCC | 36.70 | 21757702 | |
73 | O-linked_Glycosylation | TPCKNAGTCHVVDHG CCCCCCCCEEEEECC | 9.31 | 21757702 | |
94 | O-linked_Glycosylation | CSCPLGFSGPLCLTP ECCCCCCCCCEEECC | 37.39 | 22310717 | |
116 | O-linked_Glycosylation | NPCRNGGTCDLLTLT CCCCCCCCCCEEEEE | 12.30 | 21757702 | |
146 | O-linked_Glycosylation | QQADPCASNPCANGG CCCCCCCCCCCCCCC | 48.28 | 21757702 | |
194 | O-linked_Glycosylation | GLCRHGGTCHNEIGS CCCCCCCCCCHHHCC | 18.38 | 21757702 | |
232 | O-linked_Glycosylation | SPCQNGGTCRPTGDT CCCCCCCCCCCCCCC | 13.52 | 28089369 | |
311 | O-linked_Glycosylation | NACQNGGTCHNTHGG CHHHCCCCCCCCCCC | 16.40 | 28089369 | |
341 | O-linked_Glycosylation | ENIDDCASAACFQGA CCHHHHHHHHHHCCC | 23.80 | 21757702 | |
349 | O-linked_Glycosylation | AACFQGATCHDRVAS HHHHCCCCCCHHHHE | 19.73 | 28089369 | |
378 | O-linked_Glycosylation | HLNDACISNPCNEGS ECCCCCCCCCCCCCC | 34.30 | 21757702 | |
405 | O-linked_Glycosylation | CTCPSGYTGPACSQD EECCCCCCCCCCCCC | 39.97 | 22310717 | |
435 | O-linked_Glycosylation | KCLNTLGSFECQCLQ HHHHHCCCEECEECC | 22.45 | 30127001 | |
458 | O-linked_Glycosylation | IDVNECISNPCQNDA ECHHHHHCCCCCCCC | 46.51 | 21757702 | |
466 | O-linked_Glycosylation | NPCQNDATCLDQIGE CCCCCCCCHHHHCCC | 19.23 | 21757702 | |
496 | O-linked_Glycosylation | INTDECASSPCLHNG ECCHHHCCCCCCCCC | 46.61 | 21757702 | |
534 | O-linked_Glycosylation | YDVDECASTPCKNGA ECHHHHCCCCCCCCC | 44.53 | 21757702 | |
609 | O-linked_Glycosylation | TNINECHSQPCRHGG CCHHHHCCCCCCCCC | 47.69 | 21757702 | |
617 | O-linked_Glycosylation | QPCRHGGTCQDRDNS CCCCCCCCCCCCCCC | 16.16 | 22310717 | |
647 | O-linked_Glycosylation | INLDDCASNPCDSGT ECHHHHCCCCCCCCC | 47.86 | 21757702 | |
692 | O-linked_Glycosylation | SPCHNGGTCEDGIAG CCCCCCCCCCCCCCC | 17.70 | 28089369 | |
722 | O-linked_Glycosylation | SEVNECNSNPCIHGA HHHHHHCCCCCCCCC | 54.53 | 21757702 | |
759 | O-linked_Glycosylation | INNNECESNPCVNGG CCCCCCCCCCCCCCC | 58.70 | 21757702 | |
767 | O-linked_Glycosylation | NPCVNGGTCKDMTSG CCCCCCCCCCCCCCC | 20.13 | 21757702 | |
784 | O-linked_Glycosylation | CTCREGFSGPNCQTN EEECCCCCCCCCCCC | 65.28 | 22310717 | |
797 | O-linked_Glycosylation | TNINECASNPCLNQG CCHHHHHCCCCCCCC | 53.62 | 21757702 | |
805 | O-linked_Glycosylation | NPCLNQGTCIDDVAG CCCCCCCCCHHHCCC | 9.12 | 21757702 | |
888 | N-linked_Glycosylation | GASCQNTNGSYRCLC CCCCCCCCCCEEEEE | 44.99 | - | |
900 | O-linked_Glycosylation | CLCQAGYTGRNCESD EEECCCCCCCCCCCC | 28.84 | 22310717 | |
921 | O-linked_Glycosylation | NPCHNGGSCTDGINT CCCCCCCCCCCCCCH | 18.42 | 28089369 | |
951 | O-linked_Glycosylation | EDINECASNPCQNGA HHHHHHHCCCCCCCC | 53.62 | 21757702 | |
959 | N-linked_Glycosylation | NPCQNGANCTDCVDS CCCCCCCCCCCCCCC | 30.53 | - | |
997 | O-linked_Glycosylation | SSCFNGGTCVDGINS CCCCCCCEECCCCCC | 15.68 | 28089369 | |
1027 | O-linked_Glycosylation | YDVNECDSRPCLHGG EECCCCCCCCCCCCC | 50.18 | 21757702 | |
1035 | O-linked_Glycosylation | RPCLHGGTCQDSYGT CCCCCCCCCCCCCCC | 16.16 | 21757702 | |
1065 | O-linked_Glycosylation | NLVRWCDSAPCKNGG CHHHHHHCCCCCCCC | 30.86 | 21757702 | |
1159 | O-linked_Glycosylation | NPCQNGATCTDYLGG CCCCCCCCCCHHCCC | 19.82 | 28089369 | |
1179 | N-linked_Glycosylation | VAGYHGSNCSEEINE EEECCCCCCHHHHHH | 37.62 | - | |
1189 | O-linked_Glycosylation | EEINECLSQPCQNGG HHHHHHHCCCCCCCC | 43.67 | 21757702 | |
1197 | O-linked_Glycosylation | QPCQNGGTCIDLTNS CCCCCCCCEEECCCC | 14.00 | 21757702 | |
1241 | N-linked_Glycosylation | RSPKCFNNGTCVDQV CCCCCCCCCCEEEEC | 27.22 | - | |
1273 | O-linked_Glycosylation | GDVNECLSNPCDPRG CCHHHHHCCCCCCCC | 50.84 | 21757702 | |
1362 | O-linked_Glycosylation | LRCLNGGTCISGPRS EEECCCCCCCCCCCC | 14.20 | 21757702 | |
1379 | O-linked_Glycosylation | CLCLGSFTGPECQFP EEEECCCCCCCCCCC | 54.23 | 28089369 | |
1402 | O-linked_Glycosylation | NPCYNQGTCEPTSEN CCCCCCCCCCCCCCC | 12.16 | 28089369 | |
1489 | N-linked_Glycosylation | NFNDPWKNCTQSLQC CCCCCCCCCCHHHHH | 30.14 | - | |
1587 | N-linked_Glycosylation | LPPDQLRNNSFHFLR CCHHHHCCCCHHHHH | 58.03 | - | |
1635 | Phosphorylation | KHPIKRSTVGWATSS HCCCCHHHCCHHHHH | 27.37 | 27357545 | |
1640 | Phosphorylation | RSTVGWATSSLLPGT HHHCCHHHHHCCCCC | 16.61 | 27357545 | |
1641 | Phosphorylation | STVGWATSSLLPGTS HHCCHHHHHCCCCCC | 15.96 | 27357545 | |
1642 | Phosphorylation | TVGWATSSLLPGTSG HCCHHHHHCCCCCCC | 29.57 | 27357545 | |
1647 | Phosphorylation | TSSLLPGTSGGRQRR HHHCCCCCCCCCCCC | 23.43 | 27357545 | |
1749 | Ubiquitination | CGVLLSRKRRRQHGQ HHHHHCHHHHHHCCC | 47.05 | 15240571 | |
1764 | Acetylation | LWFPEGFKVSEASKK CCCCCCCCCCHHHHH | 56.56 | 37798803 | |
1770 | Acetylation | FKVSEASKKKRREPL CCCCHHHHHHCCCCC | 70.17 | 37798847 | |
1771 | Acetylation | KVSEASKKKRREPLG CCCHHHHHHCCCCCC | 49.36 | 37798819 | |
1772 | Acetylation | VSEASKKKRREPLGE CCHHHHHHCCCCCCC | 61.50 | 37798811 | |
1785 | Acetylation | GEDSVGLKPLKNASD CCCCCCCCCCCCCCC | 42.23 | 37798799 | |
1785 | Ubiquitination | GEDSVGLKPLKNASD CCCCCCCCCCCCCCC | 42.23 | 22790023 | |
1791 | Phosphorylation | LKPLKNASDGALMDD CCCCCCCCCCCCCCC | 46.07 | - | |
1851 | Phosphorylation | RMSAMAPTPPQGEVD HHHHCCCCCCCCCCC | 37.75 | 25266776 | |
1856 (in isoform 2) | O-linked_Glycosylation | - | 31.79 | 22310717 | |
1931 | Phosphorylation | LAARYSRSDAAKRLL HHHHHCCHHHHHHHH | 26.17 | 25266776 | |
1935 | Acetylation | YSRSDAAKRLLEASA HCCHHHHHHHHHHHC | 45.35 | 37798843 | |
1945 | Hydroxylation | LEASADANIQDNMGR HHHHCCCCCCCCCCC | 32.76 | 17573339 | |
2012 | Hydroxylation | INSHADVNAVDDLGK HHCCCCCCCCCHHHH | 34.49 | 17573339 | |
2050 | Acetylation | NKDMQNNKEETPLFL CHHHCCCCCCCCHHH | 65.56 | 37798823 | |
2068 | Acetylation | EGSYETAKVLLDHFA CCCHHHHHHHHHHHC | 40.61 | 37798835 | |
2111 | Phosphorylation | DEYNLVRSPQLHGTA HHCCCCCCCCCCCCC | 14.98 | 30635358 | |
2117 | Phosphorylation | RSPQLHGTALGGTPT CCCCCCCCCCCCCCC | 14.15 | 30635358 | |
2122 | Phosphorylation | HGTALGGTPTLSPTL CCCCCCCCCCCCCCC | 15.99 | 30635358 | |
2124 | Phosphorylation | TALGGTPTLSPTLCS CCCCCCCCCCCCCCC | 39.44 | 30635358 | |
2126 | Phosphorylation | LGGTPTLSPTLCSPN CCCCCCCCCCCCCCC | 20.51 | 30635358 | |
2128 | Phosphorylation | GTPTLSPTLCSPNGY CCCCCCCCCCCCCCC | 36.70 | 30635358 | |
2131 | Phosphorylation | TLSPTLCSPNGYLGN CCCCCCCCCCCCCCC | 25.22 | 30635358 | |
2135 | Phosphorylation | TLCSPNGYLGNLKSA CCCCCCCCCCCHHHH | 20.34 | 30635358 | |
2146 | Acetylation | LKSATQGKKARKPST HHHHHCCCCCCCCCC | 33.18 | 37798831 | |
2147 | Acetylation | KSATQGKKARKPSTK HHHHCCCCCCCCCCC | 61.32 | 37798815 | |
2150 | Acetylation | TQGKKARKPSTKGLA HCCCCCCCCCCCCCC | 48.45 | 37798807 | |
2152 | Phosphorylation | GKKARKPSTKGLACG CCCCCCCCCCCCCCC | 45.87 | - | |
2154 | Acetylation | KARKPSTKGLACGSK CCCCCCCCCCCCCCH | 57.15 | 37798853 | |
2161 | Acetylation | KGLACGSKEAKDLKA CCCCCCCHHHHHHHH | 47.15 | 37798827 | |
2164 | Acetylation | ACGSKEAKDLKARRK CCCCHHHHHHHHHHH | 65.76 | 37798839 | |
2253 | Methylation | AALAGGSRLAFEPPP HHHHCCCCCCCCCCC | 33.05 | 113703801 | |
2253 | Dimethylation | AALAGGSRLAFEPPP HHHHCCCCCCCCCCC | 33.05 | - | |
2262 | Dimethylation | AFEPPPPRLSHLPVA CCCCCCCCCCCCCCC | 55.38 | - | |
2262 | Methylation | AFEPPPPRLSHLPVA CCCCCCCCCCCCCCC | 55.38 | 113703805 | |
2303 | Methylation | GQCEWLPRLQNGMVP CCCCCHHHHCCCCCC | 46.89 | 113704199 | |
2303 | Dimethylation | GQCEWLPRLQNGMVP CCCCCHHHHCCCCCC | 46.89 | - | |
2317 | Methylation | PSQYNPLRPGVTPGT CCCCCCCCCCCCCCC | 27.47 | 113704205 | |
2317 | Dimethylation | PSQYNPLRPGVTPGT CCCCCCCCCCCCCCC | 27.47 | - | |
2361 | Methylation | YQGLPNTRLATQPHL HCCCCCCCCCCCCCE | 29.03 | 818913801 | |
2487 | Phosphorylation | VPEHPFLTPSPESPD CCCCCCCCCCCCCCC | 23.31 | 17646409 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
1791 | S | Phosphorylation | Kinase | PRKCZ | Q05513 | GPS |
2152 | S | Phosphorylation | Kinase | PIM1 | P11309 | PSP |
2152 | S | Phosphorylation | Kinase | PIM2 | Q9P1W9 | PSP |
2152 | S | Phosphorylation | Kinase | PIM3 | Q86V86 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | Fbxw7 | Q8VBV4 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | Itch | Q8C863 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NOTC1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SMRD3_MOUSE | Smarcd3 | physical | 17210915 | |
DLL1_MOUSE | Dll1 | physical | 21985982 | |
NUMB_MOUSE | Numb | physical | 20844536 | |
NUMB_HUMAN | NUMB | physical | 21356309 | |
SUH_MOUSE | Rbpj | physical | 17526737 | |
XIAP_HUMAN | XIAP | physical | 17318174 | |
EGFL7_HUMAN | EGFL7 | physical | 19503073 | |
EGFL7_MOUSE | Egfl7 | physical | 19503073 | |
JAG1_RAT | Jag1 | physical | 19503073 | |
SUH_HUMAN | RBPJ | physical | 19503073 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Hydroxylation | |
Reference | PubMed |
"Asparaginyl hydroxylation of the Notch ankyrin repeat domain byfactor inhibiting hypoxia-inducible factor."; Coleman M.L., McDonough M.A., Hewitson K.S., Coles C., Mecinovic J.,Edelmann M., Cook K.M., Cockman M.E., Lancaster D.E., Kessler B.M.,Oldham N.J., Ratcliffe P.J., Schofield C.J.; J. Biol. Chem. 282:24027-24038(2007). Cited for: X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1899-2106 IN COMPLEX WITHHIF1AN; IRON AND 2-OXOGLUTARATE, HYDROXYLATION AT ASN-1945 ANDASN-2012, MUTAGENESIS OF ASN-1945 AND ASN-2012, AND MASS SPECTROMETRY. | |
"Interaction with factor inhibiting HIF-1 defines an additional modeof cross-coupling between the Notch and hypoxia signaling pathways."; Zheng X., Linke S., Dias J.M., Zheng X., Gradin K., Wallis T.P.,Hamilton B.R., Gustafsson M., Ruas J.L., Wilkins S., Bilton R.L.,Brismar K., Whitelaw M.L., Pereira T., Gorman J.J., Ericson J.,Peet D.J., Lendahl U., Poellinger L.; Proc. Natl. Acad. Sci. U.S.A. 105:3368-3373(2008). Cited for: PROTEIN SEQUENCE OF 1937-1952 AND 1995-2019, FUNCTION, INTERACTIONWITH HIF1AN, HYDROXYLATION AT ASN-1945 AND ASN-2012 BY HIF1AN,MUTAGENESIS OF ASN-1945 AND ASN-2012, AND MASS SPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Monoubiquitination and endocytosis direct gamma-secretase cleavage ofactivated Notch receptor."; Gupta-Rossi N., Six E., LeBail O., Logeat F., Chastagner P., Olry A.,Israel A., Brou C.; J. Cell Biol. 166:73-83(2004). Cited for: UBIQUITINATION AT LYS-1749, AND ENDOCYTOSIS. |